James Murrough: Clinical Trials

3 trials sponsored by James Murrough, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

3 completed. 3 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 23Completed 3

Follow James Murrough: new trials by email

Trials (filtered) newest first · largest first

All 3 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
XEN1101 for Major Depressive Disorder
XEN1101, Placebo - Major Depressive Disorder
Phase 2CompletedJames Murrough602021-10-192026-11-06
Study to Treat Major Depressive Disorder With a New Medication
Ezogabine, Placebos - Depressive Disorder, Anhedonia
Phase 2CompletedJames Murrough452017-09-252020-10-23
Nuedexta in Treatment-Resistant Major Depression
dextromethorphan/quinidine - Major Depressive Disorder, Treatment Resistant
Phase 2CompletedJames Murrough202013-07-012018-06-11

Conditions studied

Depression (3)  ·  Anhedonia (2)  ·  Depressive Disorder, Major (2)  ·  Depressive Disorder (1)

Interventions

XEN1101 (1)  ·  dextromethorphan - quinidine combination (1)  ·  ezogabine (1)

Countries

United States (3)

Top investigators

James W Murrough, MD, PhD (1)

Results publications

PMID 28478356, PMID 33653118, PMID 41001561

NIH funding

R33MH111932 (1), R61MH111932 (1)